Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting

Area of Science:

• Rheumatology and Dermatology
• Translational Research
• Clinical Data Science

Background:

• Psoriatic disease research faces knowledge gaps in etiopathogenesis and management.
• Existing investigator networks collect valuable clinical and biological data.
• Leveraging these resources is key to advancing psoriatic disease understanding.

Purpose of the Study:

• To establish the GRAPPA Collaborative Research Network (CRN) to address research gaps.
• To outline priorities for CRN infrastructure, collaboration, and funding.
• To identify key research areas for psoriatic disease investigation.

Main Methods:

• Developing infrastructure for biosample and clinical data collection/storage.
• Establishing best practices for sample handling.
• Engaging the GRAPPA community, industry, and government for collaboration.
• Defining a sustainable funding strategy.

Main Results:

• Identified 4 flagship research areas: predictors of treatment response, structural damage, PsC to PsA progression, and comorbidity impact.
• Priorities include infrastructure, best practices, community engagement, and funding.
• The CRN aims to facilitate high-quality research addressing patient and clinician needs.

Conclusions:

• A GRAPPA-CRN will enable collaborative, high-quality research exceeding individual center capabilities.
• This network will accelerate advancements in psoriatic disease understanding and patient care.
• The CRN will foster collaboration among patients, clinicians, scientists, industry, and governments.